Broncus Holding Medical Device Enters Special Review in China
MT Newswires Live
Jan 13
Broncus Holding's (HKG:2216) medical device BroncTarget has entered a special review in China, according to a Hong Kong bourse filing Monday.
The device entered China's Innovative Medical Device Special Review Procedure to treat a lung condition known as chronic obstructive pulmonary disease.
The designation offers multiple benefits, including faster reviews.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.